Card image cap

Marsha Blackburn's Public Statements on Issue: Drugs

Office:

On The Ballot: Running, Republican for U.S. Senate (TN) - Sr

2

Current Issue:

Drugs

Current Speech Type:

Letter

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Date Title
10/19/2023 Ernst: End the Flow of Fentanyl Through Facebook
10/19/2022 Letter to Robert Califf, Commissioner of the Food and Drug Administration - Lankford Questions FDA's Response to Opioid Epidemic
09/13/2022 Letter to Social Media CEOs - Hyde-smith, Colleagues Push for Accountability From Social Media Giants for Fentanyl Crisis
08/15/2022 Letter to Rahul Gupta, Director of the Office of National Drug Policy - Appalachian Senators Press Office of National Drug Control Policy on Grant Assistance for High Intensity Drug Trafficking Areas
02/15/2022 Letter to Joseph R. Biden, President of the United States - Grassley Denounces Biden Administration's Plan To Fund Smoking Kits And "Safe Injection Sites'
02/15/2022 Letter to Hon. Joseph Biden, President of the United States - Tillis Denounces Biden Administration's Plan to Fund Smoking Kits and "Safe Injection Sites'
08/25/2021 Letter to Dick Durbin, Chair of Senate Judiciary Commnittee - Sen. Cruz, Judiciary Republicans Push for Fentanyl Hearing as Life-Saving Deadline Looms
03/17/2021 Letter to the Honorable Gene L. Dodaro, Comptroller General - Rubio, Capito, GOP Colleagues: Biden Escalating Border Crisis by Unlawfully Freezing Border Wall Funding
06/08/2018 Letter to the Hon. Scott Gottlieb, Commissioner of Food and Drugs - Bipartisan E&C Leaders Request Information from FDA About Efforts to Stop the Importation of Illegal Opioids
10/25/2017 Letter to Eric Hargan, Acting Secretary of Health and Human Services and Robert Patterson, Acting Administrator of the United States Drug Enforcement Administration - Blackburn presses HHS, DEA on missing report on opioid law
10/28/2015 Letter to Howard Shelanski, Administrator, Office of Information and Regulatory Affairs - Halt Harmful Opioid Rule
04/22/2014 Letter to Margaret Hamburg, Commissioner of US Food and Drug Administration - Committee Presses FDA for Documents On Trial Lawyers' Role in Proposed Changes to Generic Drug Labeling
05/04/2012 Letter to Attorney General Holder and Secretary Sebelius
arrow_upward